Pfizer pulling leukemia drug called Mylotarg from US market
It is being reported that Pfizer will be pulling a leukemia drug called Mylotarg from the US market after a follow up study showed that it does not work.
Market reports suggested that Pfizer Inc. has got the approval from US FDA to expand the marketing of the cancer drug.